ClinicalTrials.gg
Sign In

Cicatrix, Hypertrophic clinical trials

The registry lists 129 studies for Cicatrix, Hypertrophic across more than 10 countries. 31 are recruiting or about to start. 85 of them are mainly about Cicatrix, Hypertrophic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-02.

Get an email when these change. Save the Cicatrix, Hypertrophic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
52
Status unknown
29
Recruiting
19
Not yet recruiting
11
Withdrawn
10
Terminated
6

Phase

Phase 2
28
Phase 3
14
Phase 4
9
Phase 1
8
Early Phase 1
3

Where

United States
38
Egypt
14
Canada
8
China
7
Taiwan
6
Korea, Republic of
5

Who runs them

Cairo University (10) · The Hong Kong Polytechnic University (3) · Pfizer (3) · Mahidol University (3) · Hangang Sacred Heart Hospital (3) · Massachusetts General Hospital (3) · Kaohsiung Veterans General Hospital. (2) · RXi Pharmaceuticals, Corp. (2)

What is being tested here

Drugs under test in Cicatrix, Hypertrophic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Triamcinolone Acetonide102
Triamcinolone102
ETD001101
Fluorouracil101
Polidocanol101
Remimazolam besilate101
Remimazolam101
Propofol101
Bimatoprost101
Botulinum toxin type A014

Drug classes tested here Corticosteroids 1 open

Coming up

3phase 3 studies under way
11studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 19 Cicatrix, Hypertrophic studies recruiting now, 8 (42%) set no upper age limit and 10 (53%) stop at 75 or younger. 1 (5%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 5 (26%) take healthy volunteers.

Recruiting studies that take each age, of 19
AgeWomenMen
101 (5%)1 (5%)
1817 (89%)17 (89%)
3019 (100%)19 (100%)
4019 (100%)19 (100%)
5018 (95%)18 (95%)
6515 (79%)15 (79%)
7510 (53%)10 (53%)
859 (47%)9 (47%)

Across all 129 studies, recruiting or not: 57% stop at 75 or younger and 47% at 65; 17% take children; 7% are for women only and 1% for men only; 31% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Cicatrix, Hypertrophic studies take

Of 33 interventional studies with no phase under Cicatrix, Hypertrophic, half reached primary completion within 18 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase18 mo12–30 · 33 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 129. Browse all 129 → or search them.